Specifically, BRAF mutation alone was associated with older patient age (≥ 45 years) (P = 0.042), larger tumor size (P = 0.032), extrathyroidal invasion (P = 0.012), advanced stage (P = 0.022), and higher MAICS score (P = 0.002). The gene discussed is BRAF; the disease is neoplasm.